网站大量收购闲置独家精品文档,联系QQ:2885784924

高润霖-冠心病介入治疗的热点-2008演示文稿.ppt

高润霖-冠心病介入治疗的热点-2008演示文稿.ppt

  1. 1、本文档共81页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
演示文稿演讲PPT学习教学课件医学文件教学培训课件

COURAGE: Treatment effect on hospitalization for ACS Boden WE et al. N Engl J Med. 2007;356:1503-16. *Unadjusted HR 1.07 (0.84-1.37) P = 0.56* No. at risk Medical therapy PCI 127 134 236 246 418 431 662 667 833 835 956 957 1025 1027 1138 1149 Survival free of ACS Years 0 0 1 2 3 4 5 6 7 1.0 0.9 0.7 0.8 PCI + medical therapy Medical therapy COURAGE: Treatment effect on angina Boden WE et al. N Engl J Med. 2007;356:1503-16. P 0.001 P = 0.02 NS Angina-free (%) NS Boden WE et al. N Engl J Med. 2007;356:1503-16. Treatment effect in CV and diabetes subgroups 0.25 0.50 1.00 2.00 1.75 1.50 Medical therapy better PCI better Myocardial infarction Yes No Extent of CAD Multivessel disease Single-vessel disease Diabetes Yes No Angina CCS 0-I CCS II-III Ejection fraction 50% Previous CABG No Yes ≤50% Baseline characteristics Hazard ratio (95% CI) PCI + OMT compared to OMT resulted in: Significantly less use of nitrates at - 1 year (53% vs. 67%) - 3 years (47% vs. 61%) - 5 years (40% vs. 57%) Significantly less use of Ca+2 channel blockers at - 1 year (40% vs. 49%) - 3 years (43% vs. 50%) - 5 years (42% vs. 52%) Freedom from Anti-anginal Meds During Long-term Follow-up Despite a much higher than anticipated XO to PCI in the OMT group Boden WE et al. NEJM 2007;356:1503-16 Follow-up PCI + OMT OMT P Value Baseline 51 + 25 51 + 25 0.83 3 months 73 + 22 68 + 23 0.0001 6 months 73 + 23 70 + 23 0.0005 12 months 75 + 21 71 + 22 0.0006 24 months 76 + 21 74 + 22 0.11 36 months 77 + 21 75 + 22 0.05 SAQ Domain Quality of Life Boden and Weintraub, ACC 2007. 不适宜长期双重抗血小板治疗的情况 计划中的非心脏手术 支架血栓形成的高危患者 出血并发症风险增加 高龄,贫血,肾功能衰竭,消化道出血后, 低体重 需长期服口服抗凝剂者 房颤、肺栓塞、机械瓣置换术后 不愿意或不能长期按医嘱服药者 Summary Long-term efficacy of DES is persistent and the safety of DES is confirmed by meta-analysis based on patients level Late stent thrombosis after DES implantation has emerged as a concerning entity Indication for DES stenting Proper dual antiplatelet therapy, at least 1year

文档评论(0)

yuzongxu123 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档